Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection
Clinical trial NCT02910557 · COMPLETED
Trial details
- NCT number
- NCT02910557
- Sponsor
- Amgen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-08-10
- Primary completion
- 2026-01-30
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.